pharma-company /Medicinal products /Active ingredients

Rx · PZN 17512365

NUCALA 40 mg solution for injection in a pre-filled syringe

German trade nameNUCALA 40 mg Injektionslösung in einer Fertigspritze

Active ingredientMepolizumabPharmaceutical formSolution for injection/infusion

Only sporadically available

1.2

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €400

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for NUCALA 40 mg solution for injection in a pre-filled syringe.

Review purchasing terms

NUCALA 40 mg solution for injection in a pre-filled syringe contains the active ingredient Mepolizumab and comes as Solution for injection/infusion. One pack size is recorded (PZN 17512365). The pharma availability index for German wholesale stands at 1.2 out of 10 over the past 30 days – the pack was therefore only sporadically available.

NUCALA 40 mg solution for injection in a pre-filled syringe was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

More products containing Mepolizumab

NUCALA 100 mg solution for injection in a pre-filled syringe9.6NUCALA 100 mg solution for injection in the pre-filled pen9.4NUCALA 100 mg powder for preparation of a solution for injection0.0
Active ingredient overview: Mepolizumab →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.